Palisade Bio terminates Chief Medical Officer Michael Dawson, effective Oct 11, 2022

PALISADE BIO, INC.

Michael Dawson, MD, terminated as Chief Medical Officer effective October 11, 2022.
No successor or interim CMO named in the filing.
Departure may impact clinical development strategy for Palisade Bio (PALI).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Dawson

Chief Medical Officer

PALI · PALISADE BIO, INC.

Effective: 2022-10-11
Filed: October 17, 2022, 7:59 PM ET

the employment of Michael Dawson, MD, was terminated by Palisade Bio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Dawson was terminated as Chief Medical Officer at PALISADE BIO, INC..

Action: terminated
Role: Chief Medical Officer

Exact text from the filing

the employment of Michael Dawson, MD, was terminated by Palisade Bio, Inc.

View on SEC.gov

PALISADE BIO, INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-028556

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.